Honduras vs Syria: The number of people with susceptibility test result for rifampicin
Honduras
690
in 2021
Syria
705
in 2021
Honduras rank
72nd
Syria rank
71st
The number of people with susceptibility test result for rifampicin over time
- Honduras
- Syria
How they compare
Syria currently reports 705 against 690 in Honduras, a difference of 15.
The two have swapped places 1 time across 5 shared years of data; in 2017 it was Honduras ahead.
Honduras ranks 72nd and Syria ranks 71st of 155 countries.
Across the 2 decades both report, Honduras averaged higher in 1 and Syria in 1.
Head to head by decade
| Decade | Honduras | Syria | Difference | Ahead |
|---|---|---|---|---|
| 2010s | 887.33 | 491.33 | 396 | Honduras |
| 2020s | 796 | 808.5 | 12.5 | Syria |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher the number of people with susceptibility test result for rifampicin, Honduras or Syria?
- Syria, at 705 against 690 in Honduras as of 2021.
- What is the difference in the number of people with susceptibility test result for rifampicin between Honduras and Syria?
- 15, with Syria ahead.
- How many years of comparable data are there for Honduras and Syria?
- 5 years are reported by both, from 2017 to 2021.
- How do Honduras and Syria rank globally for the number of people with susceptibility test result for rifampicin?
- Honduras ranks 72nd and Syria ranks 71st of 155 countries.
- Where does this data come from?
- World Health Organization, Global Health Observatory, published as The number of people with susceptibility test result for rifampicin among bacteriologically confirmed pulmonary TB patients.. Statizoid refreshes it automatically from the source and publishes the full history for both places.